-transparent.png){kind=logo}
There are no definite criteria for the indication of surgery in lung cancer with mediastinal lymph node involvement. During the past 20 years, 100 patients (76 patients with adenocarcinoma and 24 patients with squamous cell carcinoma) have undergone thoracotomy for lung cancer with mediastinoscopic positive lymph nodes at our hospital. Of these, relatively curative resection was performed on 13 patients. The 5-year survival rate in these 13 patients was 28%, which was significantly higher than the 0% in 42 patients with relatively non-curative resection and the 0% in 26 patients with absolutely non-curative resection. The 5-year survival rate was 9% in both T1 (n = 14) patients and T2 (n = 37) patients. No T3 (n = 21) and T4 (n = 9) patients survived 3 years. The 5 year survival rate in patients with squamous cell carcinoma was 12% and that in patients with adenocarcinoma was 0%, but there was no significant difference. The survival rates of T1 and T2 patients were significantly higher than that of T3 patients (p less than 0.02 and p less than 0.005) respectively. Contralateral mediastinal lymph node metastasis (N3) was observed significantly more frequently in patients with adenocarcinoma (38%) than in those with squamous cell carcinoma (13%), but there was no significant difference in the survival rate. In N2 patients, the survival rate was compared between those with mediastinal nodal involvement of an early stage (N2-1) and those with lymph node metastasis of more advanced stage (N2-2) according to the lobe bearing the primary cancer.(ABSTRACT TRUNCATED AT 250 WORDS)
T Funatsu, and
Y Matsubara, and
Y Yasuda, and
S Kosaba, and
M Adachi, and
T Konishi, and
W Chiba, and
S Sawai, and
R Hatakenaka, and
S Ikeda
June 1977,
Kyobu geka. The Japanese journal of thoracic surgery,
T Funatsu, and
Y Matsubara, and
Y Yasuda, and
S Kosaba, and
M Adachi, and
T Konishi, and
W Chiba, and
S Sawai, and
R Hatakenaka, and
S Ikeda
February 1976,
The Journal of thoracic and cardiovascular surgery,
T Funatsu, and
Y Matsubara, and
Y Yasuda, and
S Kosaba, and
M Adachi, and
T Konishi, and
W Chiba, and
S Sawai, and
R Hatakenaka, and
S Ikeda
September 1992,
[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai,
T Funatsu, and
Y Matsubara, and
Y Yasuda, and
S Kosaba, and
M Adachi, and
T Konishi, and
W Chiba, and
S Sawai, and
R Hatakenaka, and
S Ikeda
January 1978,
Antibiotics and chemotherapy,
T Funatsu, and
Y Matsubara, and
Y Yasuda, and
S Kosaba, and
M Adachi, and
T Konishi, and
W Chiba, and
S Sawai, and
R Hatakenaka, and
S Ikeda
August 2016,
The Annals of thoracic surgery,
T Funatsu, and
Y Matsubara, and
Y Yasuda, and
S Kosaba, and
M Adachi, and
T Konishi, and
W Chiba, and
S Sawai, and
R Hatakenaka, and
S Ikeda
February 2007,
Japanese journal of clinical oncology,
T Funatsu, and
Y Matsubara, and
Y Yasuda, and
S Kosaba, and
M Adachi, and
T Konishi, and
W Chiba, and
S Sawai, and
R Hatakenaka, and
S Ikeda
January 2007,
Hepato-gastroenterology,
T Funatsu, and
Y Matsubara, and
Y Yasuda, and
S Kosaba, and
M Adachi, and
T Konishi, and
W Chiba, and
S Sawai, and
R Hatakenaka, and
S Ikeda
October 1990,
Orvosi hetilap,
T Funatsu, and
Y Matsubara, and
Y Yasuda, and
S Kosaba, and
M Adachi, and
T Konishi, and
W Chiba, and
S Sawai, and
R Hatakenaka, and
S Ikeda
January 1994,
Kyobu geka. The Japanese journal of thoracic surgery,
T Funatsu, and
Y Matsubara, and
Y Yasuda, and
S Kosaba, and
M Adachi, and
T Konishi, and
W Chiba, and
S Sawai, and
R Hatakenaka, and
S Ikeda
January 2021,
International journal of clinical oncology,
